Cost-effectiveness of population-based genetic hemochromatosis screening

Community Genetics

Volumn 3, Issue 1, 2000, Pages 2-11

  Schöffski, Oliver ^a   Schmidtke, Jörg ^b   Stuhrmann, Manfred ^b  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Costs; Decision tree; Economic evaluation; Hemochromatosis; Screening

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; ECONOMIC ASPECT; GENETIC SCREENING; HEMOCHROMATOSIS; HUMAN; LIFE EXPECTANCY; PRIORITY JOURNAL; PUBLIC HEALTH; SCREENING TEST;

EID: 0033761666     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016220     Document Type: Article

References (34)

1. Idiopathic hemochromatosis: Demonstration of recessive transmission and early detection by family HLA typing
2. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors
3. Prevalence of haemochromatosis amongst asymptomatic Australians
4. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
5. Haemochromatosis and HLA-H. Scientific correspondence
6. Mutation analysis in hereditary haemochromatosis
7. Haemochromatosis and HLA-H. Scientific correspondence
8. Neue Moglichkeiten in der Diagnose der hereditaren Hamochromatose
9. Prevalence of the mutations Cys282Tyr and H63D in the HFE gene among German hemochromatosis patients and healthy controls
10. Haemochromatosis: A gene at last?
11. Cost-effectiveness of screening for hereditary hemochromatosis
12. Screening blood donors for hereditary hemochromatosis: Decision analysis model based on a 30-year database
13. Cost-effectiveness analysis for evaluation of screening programs: Hereditary hemochromatosis
14. Screening for hemochromatosis: A cost-effectiveness study based on 12,258 patients
15. Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers
16. Haemochromatosis: Strike while the iron is hot
17. Statistisches Bundesamt: Statistisches Jahrbuch fur die Bundesrepublik Deutschland
18. Statistisches Bundesamt: Statistisches Jahrbuch fur das Ausland
19. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis
20. Long-term survival in patients with hereditary hemochromatosis
21. Comparison of heteroduplex analysis, direct sequencing, and enzyme mismatch cleavage for detecting mutations in a large gene, FBN1
22. Validation of the determination of ΔF508 mutations of the cystic fibrosis gene in over 11,000 mouthwashes
23. Hereditary haemochromatosis mutation frequencies in the general population
24. Consensus on a framework for European guidelines - Declaration of the Euromet Group
25. Health economic guidelines: The German perspective revisited
26. Prediction of the effects and costs of breast-cancer screening in Germany
27. Five-hundred life-saving interventions and their cost-effectiveness
28. Use of blood therapeutically drawn from hemochromatosis patients
29. Active cascade testing for carriers of cystic fibrosis gene
30. Cascade testing for identification of carriers of cystic fibrosis
31. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis